glp 1 agonist drugs side effects Long-Term Of GLP-1 Medications: What You Should Know Adverse Effects of GLP-1 Receptor

Cardiovasc Ther 2013;31:238249

Gao H, Kiesewetter DO, Zhang X, Huang X, Guo N, Lang L, Hida N, Wang H, Wang H, Cao F

This was conducted at 410 sites in 32 countries

10.1056/NEJMoa2032183 90 YangJ.RenJ.SongJ.LiuF.WuC.WangX.et al (2013)

Zepbound/Wegovy vs Mounjaro/Ozempic Mounjaro and Ozempic are the diabetes versions of Zepbound and Wegovy respectively

Cardiovascular outcome trials (CVOTs) of GLP-1RAs To date, the REWIND study has demonstrated for the first time that primary cardiovascular prevention strategies can significantly reduce cardiovascular adverse events in patients with T2DM, regardless of whether or not these patients are co-diagnosed with CVD [23]